Medical-and-economic substantiation of rational antibacterial therapy for patients with pleural empyema in the conditions of the military medical institutions

We have performed a post-hoc analysis of the results of using antibacterial therapy in patients with pleural empyema. The cost-effectiveness analysis of rational and empiric antibacterial therapies was performed. The cost-effectiveness ratio for rational antibacterial therapy was lower than for empiric one (2889 and 4480 rubles for 1 treated patient correspondingly). The use of the rules of rational antibacterial therapy in practice leads to proved saving of economic costs

rational antimicrobial therapy, pleural empyema, empiric antibacterial therapy, microbiological monitoring, economic effectiveness, cost-effectiveness analysis, cost of pleural empyema treatment, economic costs